Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-pyronaridine for uncomplicated falciparum malaria in Gia Lai, Vietnam
ACTRN12622001407785Phase 4Not yet recruiting
- Sponsor
- World Health Organization
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pyronaridine in Malaria and malaria, sponsored by World Health Organization. Primary endpoints: Day 42 PCR-corrected adequate clinical and parasitological response, Adverse events and serious adverse events and 1 more. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
pyronaridine
03
Conditions
Malariamalaria
Beyond the preview
Go deeper on ACTRN12622001407785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12622001407785.